Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editor-in-Chief

    M.Waheed Roomi

    M.Waheed Roomi
    Dr. Rath Research Institute
    1260 Memorex Drive, Santa Clara, USA
    Email: w.roomi@drrath.com
    Tel: (408)730-4481
    Fax: (408) 588-7174

    More Info.

    Tsuyoshi Shirakawa

    Tsuyoshi Shirakawa
    Kyushu University, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
    Email: t-w-r@intmed1.med.kyushu-u.ac.jp
    Tel: +81-92-661-5395
    Fax: +81-955-70-1511

    More Info.


    Welcome from the desk of

    Dr. Tsuyoshi Shirakawa, MD., Executive Editor

    Welcome to our website! I am very happy for your visit.

    Global Journal of Cancer Therapy reports both clinical and experimental results related to cancer, and is using online review and Editorial Manager System for quality review process. The Journal invites all type of clinical and medical case reports, case studies, basic researches, clinical images, pharmacology and nursing, as it were, total oncology. The goal of us is to keep a record of the state-of-the-art research or case report and to promote study, research and improvement within its various specialties, then to develop total oncology.

    We believe your expertise knowledge will help in the growth of the journal and as well help many budding research scientists all around the world. Your article will be a key insight into real medical cases that are essential for physicians, and may ultimately help to improve patient outcomes.

    Editorial Board

    Maria Saridi
    Director Nursing
    University of Peloponnese
    Greece
    sarmar32@windowslive.com
    GJCT
    Research Interest: Nursing Care Delivery Systems, Community Nursing, Hospital Information Systems, Surgical Nursing, Health Education, Prevention, Nosocomial Infections, Occupational Health, Community Healthcare
    More Info.
    Ryou-U Takahashi
    Division of Molecular and Cellular Medicine
    National Cancer Center Research Institute
    Japan
    rytakaha@ncc.go.jp
    GJCT

    Research Interest: Molecular And Cell Biology, Microrna, Breast Cancer, Cancer Stem Cells


    More Info.
    Mostafa Shawky Ibrahim El-Haddad
    Assistant Professor
    Department of Clinical Oncology
    Cairo University
    Egypt
    mostafa@mostafaelhaddad.com
    GJCT

    Research Interest:  Highly Interested in Modern, Advanced Radiotherapy Techniques such as IMRT IGRT, Adaptive Radiotherapy and How to Use Them to Improve the Treatment Outcome of Cancer Patients

    More Info.
    Shinq-Jen Wu
    Da-Yeh University
    Taiwan
    jen@mail.dyu.edu.tw
    GJCT

    Research Interest: Shinq-Jen Wu, Da-Yeh University, Chang-Hwa, Taiwan


    More Info.
    Ana Livia Silva Galbiatti
    Faculdade de Medicina de São José do Rio Preto
    Brazil
    analivia_sg@yahoo.com.br
    GJCT

    Research Interest: Head And Neck Cancer, Genetics, Molecular Biology, Cell Line, Chemoterapeutics, Genetic Polymorphisms


    More Info.
    George F Samelis
    Medical Oncologist
    President of the Hellenic and International Society of Molecular
    National and Kapodistrian University of Athens
    Greece
    oncologydept.samelis@hippocratio.gr
    GJCT

    Research Interest: Lung-Pancreatic-Prostate-Cancers, Molecular Targeted Therapies


    More Info.
    Peng Zhan
    Associate Professor
    Shandong University,
    China
    zhanpeng1982@163.com
    GJCT

    Research Interest: Discovery of Novel Antiviral, Anticancer and Neurodegenerative Diseases-Related Agents Based on The Rational Drug Design Approaches.


    More Info.
    Patrizio Lancellotti
    Professor
    Cardiology
    University of Liege
    Belgium
    plancellotti@chu.ulg.ac.be
    GJCT

    Research Interest: New Insights Into The Development And Progression Of Aortic Valvestenosis (Thenid-¬‐PAS Study) Progression And Outcome Of Secondary Mitral Regurgitation (POMAR Registry)Radiation-¬‐Induced Heart Disease (AVRI Study): Animal Study Normal Reference Ranges For Echocardiography: Rationale, Study Design And Methodology(NORRE Study)


    More Info.
    Maryam Azimi Mohammadabadi
    Department of Immunology
    Tehran University of Medical Science
    Iran
    m-azimim@razi.tums.ac.ir
    GJCT

    Research Interest: Potential Therapeutic Applications of Arteether, a Semi-Synthetized Derivative of Artemisinin on a Murine Model of Breast Cancer. As a Result, I Have Got Some Experience Atan Area of Tumor Immunology/Immunotherapynamed "Chemoimmunotherapy". Chemoimmunotherapy is an Approach for the Treatment of Cancers in Whichthe Focus is to enhance the Efficacy of chemotherapeutic Agents by Concomitant Application of Compounds with Immunomodulatory Properties. Besides my Thesis Work, I Managed to Do a Course in Cellular Immunology with Professor Hassan, One of the Well-Knownimmunologists in Iran, so that i could also Work on Cellular Immunology Aspects of Tumors. Moreover, Considering the Reported Associations between Molecular Players such as CTLA-4, PDL-1 and also Different Micrornas in Tumor Progression, i am Currently Planning to further Study these Associations in order to improve the Efficacy of Tumor Immunotherapy

    More Info.
    Tomasz Skora
    Gastrointestinal and Genitourinary Cancer
    Maria Sklodowska-Curie Memorial Institute
    Poland
    tbskora@gmail.com
    GJCT

    Research Interest: Radiotherapy, Proton Therapy, Particle Therapy, Gastrointestinal Cancers, Genitourinary Cancers, Anal Canal Cancer, Rectal Cancer, Gastric Cancer, Seminoma, Bladder Cancer, Prostate Cancer


    More Info.
    Hikmat N Abdel-Razeq
    Deputy Director General
    King Hussein Cancer Center
    University of Jordan
    Jordan
    habdelrazeq@KHCC.JO
    GJCT

    Research Interest: Clinical Oncology

    More Info.
    Qinong Ye
    Professor
    Department of Medical Molecular Biology/Oncology
    Beijing Institute of Biotechnology
    China
    yeqn66@yahoo.com
    GJCT

    Research Interest: Molecular Basis Of Cancer; Cell Signaling; Epigenetics; DNA Damage Response


    More Info.
    Gang Zhao
    Professor
    Department of Pancreatic Surgery
    Huazhong University of Science and Technology
    China
    gangzhao@aliyun.com
    GJCT
    More Info.
    Leonard Amaral
    Professor
    Universidade Nova de Lisboa
    Portugal
    LAmaral@ihmt.unl.pt
    GJCT

    Research Interest: Bacteriology, Immunology, Hematology, Clinical Pathology, Chemical Pathology, Endocrinology, Cancer, Human Embryology, Methods For Clinical Laboratories


    More Info.
    Hua Yang
    Department of Cell Biology
    Peking University,
    China
    yanghua@bjmu.edu.cn
    GJCT

    Research Interest: Oncology,including basic and clinical


    More Info.
    View more
    mendeley

    A Novel Nutrient Mixture Induces Apoptosis in Human Mesothelioma Cells (MSTO-211H) via Activation of Caspases

    DOI Logo 10.17352/2581-5407.000024

    Published On: April 09, 2019 | Pages: 007 - 011

    Author(s): M Waheed Roomi, Bilwa Bhanap, Aleksandra Niedzwiecki* and Matthias Rath
    Abstract View Full Article View
    mendeley

    Synthesis of Some Aryl Ketoxime Derivatives with their in vitro Anti-microbial and Cytotoxic Activity

    DOI Logo 10.17352/gjct.000023

    Published On: March 08, 2019 | Pages: 001 - 006

    Author(s): Oguzhan Karaosmanoglu, Burcu Butun*, Hakan Dal, Hulya Sivas and Kadriye Benkli
    Abstract View Full Article View
    mendeley

    Total Oncology is necessary for Japanese new era

    DOI Logo 10.17352/2581-5407.000022

    Published On: October 13, 2018 | Pages: 001 - 003

    Author(s): Tsuyoshi Shirakawa*
    Abstract View Full Article View
    mendeley

    Video Endoscopic Inguinal Lymphadenectomy: Refi ning surgical technique after ten years experience

    DOI Logo 10.17352/gjct.000021

    Published On: December 30, 2017 | Pages: 034 - 037

    Author(s): Marcos Tobias-Machado, Pericles Rios Auad*, Victor Corona, Igor Silva, Oseas de Castro Neves, Eliney Ferreira Faria, Pablo Matos, Alexandre Cesar Santos, Roberto Machado, Aurus Dourado and Hamilton de Campos Zampolli
    Abstract View Full Article View
    mendeley

    Role of tumor heterogeneity in drug resistance

    DOI Logo 10.17352/gjct.000020

    Published On: July 20, 2017 | Pages: 032 - 033

    Author(s): Dhruv Kumar*
    Abstract View Full Article View
    mendeley

    MEK Inhibitors in Combination with Immune Checkpoint Inhibition: Should we be Chasing Colorectal Cancer or the KRAS Mutant Cancer

    DOI Logo 10.17352/gjct.000019

    Published On: May 26, 2017 | Pages: 030 - 031

    Author(s): Julius Strauss*
    Abstract View Full Article View
    mendeley

    Angiosarcoma of the Scalp and Face: A Hard to Treat Tumor

    DOI Logo 10.17352/gjct.000018

    Published On: April 15, 2017 | Pages: 026 - 029

    Author(s): Jmour Omar*, Kochbati Lotfi , Ghith Sahar and Benna Farouk
    Abstract View Full Article View
    mendeley

    The Promise of Disease Management in Greece

    DOI Logo 10.17352/gjct.000017

    Published On: March 30, 2017 | Pages: 018 - 025

    Author(s): Konstantinos Stamatiou, Richard Lacroix, Eleni Almpani, Konstantinos Katsanos, Georgios Tzitzikos and Maria Saridi*
    Abstract View Full Article View
    mendeley

    Abrikossoff’s Tumour Mimicking a Neoplastic Tumour of the Breast: A Case Report

    DOI Logo 10.17352/gjct.000016

    Published On: March 20, 2017 | Pages: 015 - 017

    Author(s): Alassiri A*, Al Ali A, Vaysse C, Escourrou G, Vinet B and Rimailho J
    Abstract View Full Article View
    mendeley

    The Role of Decavanadate in Anti- Tumour Activity

    DOI Logo 10.17352/gjct.000015

    Published On: March 11, 2017 | Pages: 012 - 014

    Author(s): M Aureliano*
    Abstract View Full Article View

     

    Clients' voices

    Readmore

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on GJCT